Paper3255103
Differences in crystal properties and ligand affinities of an antifluorescyl Fab (4-4-20) in two solvent systems.
Gibson AL and 8 others. Proteins, 1988. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Differences in crystal properties and ligand affinities of an antifluorescyl Fab (4-4-20) in two solvent systems. Papers, record 3255103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3255103
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differences in crystal properties and ligand affinities of an antifluorescyl Fab (4-4-20) in two solvent systems.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Glycols | Major topic |
| Immunoglobulin Fab Fragments | Major topic |
| Polyethylene Glycols | Major topic |
| Animals | |
| Crystallography | |
| Fluorescein | |
| Fluoresceins | |
| Fluorescence Polarization | |
| Hydrolysis | |
| Ligands | |
| Mice | |
| Mice, Inbred BALB C | |
| Solvents |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI 20960 | NIAID NIH HHS | United States | R01AI020960 | PubMed and NIH | NIH RePORTER |
| AI 22898 | NIAID NIH HHS | United States | R01AI022898 | PubMed and NIH | NIH RePORTER |
| CA 19616 | NCI NIH HHS | United States | R01CA019616 | PubMed and NIH | NIH RePORTER |
| R23AI022898 | NIH | NIH RePORTER | |||
| R37CA019616 | NIH | NIH RePORTER |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16195545 | A mutation designed to alter crystal packing permits structural analysis of a tight-binding fluorescein-scFv complex. | Protein Sci | 2005 | https://conductscience.org/library/papers/16195545 | PubMed |
| 7696460 | High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity. | Biophys J | 1994 | https://conductscience.org/library/papers/7696460 | PubMed |
| 2170983 | Antibody caging of a nuclear-targeting signal. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2170983 | PubMed |
| 1904783 | Fluorescence measurements of immune complexes of Mab 4-4-20 with isomeric haptens. | Biophys J | 1991 | https://conductscience.org/library/papers/1904783 | PubMed |
| 1420916 | Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations. | Biophys J | 1992 | https://conductscience.org/library/papers/1420916 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3255103
GET https://conductscience.org/api/papers/v1/3255103/authors